Retension Pharmaceuticals, Inc. (RTSN)
10.69
-0.03
(-0.28%)
USD |
NASDAQ |
Nov 06, 10:17
Retension Pharmaceuticals Shareholders Equity (Quarterly) : -14.92M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.92M |
| Date | Value |
|---|---|
| March 31, 2026 | -13.20M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -4.583B |
| Abeona Therapeutics, Inc. | 128.06M |
| America Great Health | -4.798M |
| Acumen Pharmaceuticals, Inc. | 34.61M |
| Aardvark Therapeutics, Inc. | 74.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.13M |
| Total Liabilities (Quarterly) | 31.05M |
| Debt to Equity Ratio | -1.888 |
| Current Ratio | 5.609 |